Drugs / abiraterone acetate
abiraterone acetate
also known as
Abiraterone accord · Abiraterone acetate component of akeega · Abiraterone krka · Abiraterone mylan · CB-7630 · NSC-748121 · NSC-749227 · TAVT-45 · +2 more
Small molecule targets CYP17A1 via inhibition
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04887506 | May 2021 → Oct 2022 | castration-resistant prostate carcinoma, metastatic prostate carcinoma | Tavanta Therapeutics | Completed | No outcome recorded |
Evidence & citations 15 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | abiraterone acetate | “TAVT-45: Administered twice daily as 1 x sachet containing TAVT-45 (250 mg abiraterone acetate), reconstituted in water or specified fruit juice (orange juice), + Prednisone (5...” NCT04887506 ↗ |
| Known as | Abiraterone accord | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | Abiraterone acetate component of akeega | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | Abiraterone krka | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | Abiraterone mylan | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | CB-7630 | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | NSC-748121 | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | NSC-749227 | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | TAVT-45 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04887506 ↗ |
| Known as | Yonsa | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Known as | Zytiga | ChEMBL registry synonym — accepted as the source's own label CHEMBL271227 ↗ |
| Action | Inhibit | “Cytochrome P450 17A1 inhibitor” CHEMBL271227 ↗ |
| Modality | Small molecule | — CHEMBL271227 ↗ |
| Route | Oral | “250 mg abiraterone acetate granules for oral suspension” NCT04887506 ↗ |
| Target | CYP17A1 | “Cytochrome P450 17A1 inhibitor” CHEMBL271227 ↗ |